Total submissions: 4
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV000901349 | SCV001045715 | likely benign | not provided | 2023-06-21 | criteria provided, single submitter | clinical testing | |
ARUP Laboratories, |
RCV003741233 | SCV004564811 | likely benign | Hereditary spherocytosis type 1 | 2023-05-11 | criteria provided, single submitter | clinical testing | |
Ce |
RCV000901349 | SCV004811067 | likely benign | not provided | 2024-03-01 | criteria provided, single submitter | clinical testing | ANK1: BP4 |
Ambry Genetics | RCV004629377 | SCV005137300 | likely benign | Inborn genetic diseases | 2024-05-14 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |